• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗阻训练在减轻癌症恶病质中的作用:一项系统综述。

The role of resistance training in mitigating cancer-induced cachexia: A systematic review.

作者信息

Horawski Jennifer L, Fleszar-Pavlovic Sara E, Lopez-Pentecost Melissa, Crane Tracy E, Wheeler Madalyn G, Kholodovsky Eric, Best Thomas M

机构信息

Division of Sports Medicine, Department of Orthopaedics, University of Miami Miller School of Medicine, Miami, FL, USA.

Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

Sports Med Health Sci. 2025 Jan 21;7(5):384-392. doi: 10.1016/j.smhs.2025.01.002. eCollection 2025 Sep.

DOI:10.1016/j.smhs.2025.01.002
PMID:40936667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12421196/
Abstract

BACKGROUND

Cancer induced cachexia, the involuntary loss of lean body mass and adipose tissue, is a debilitating syndrome experienced in up to 80% of all cancer patients. Cachexia is associated with poor treatment outcomes including decreased quality of life, increased risk of infection, disease progression, and mortality. Recent research suggests that exercise interventions may improve cachexia; however, there is a need for comprehensive and systematic review of the literature to evaluate the role of specific interventions on cancer-induced cachexia.

METHODS

We conducted a systematic review examining the efficacy of physical activity interventions, particularly resistance training, on cancer-induced cachexia outcomes. We searched seven electronic databases (PubMed, Embase, EBSCO, SCOPUS, Web of Science, PsychINFO, Cochrane) for articles published up to September 2023, yielding 7 eligible studies.

RESULTS

Sample sizes ranged from 20 to 190 participants per study. Studies included pancreatic ( ​= ​3), head & neck ( ​= ​3), and Gastrointestinal ( ​= ​1) cancers. Mean age ranged from 51.90 to 67.1 years old and females comprised 51% of the participants. Most studies implemented resistance training interventions (73%), ranging from 3 months to 6 months in duration. Although the patterns of outcomes indicate promising results, the effect sizes for all models were small and not statistically significant.

CONCLUSIONS

The science of exercise interventions to improve outcomes in those with cancer-related cachexia is still emerging although progressive resistance training appears to be the most promising countermeasure. Authors encourage the development of high-quality, fully powered randomized controlled trials (RCTs) examining physical exercise interventions aimed at mitigating cancer-induced cachexia.

摘要

背景

癌症诱发的恶病质是指瘦体重和脂肪组织的非自愿性丧失,是高达80%的癌症患者都会经历的一种使人衰弱的综合征。恶病质与不良治疗结果相关,包括生活质量下降、感染风险增加、疾病进展和死亡率上升。近期研究表明,运动干预可能改善恶病质;然而,需要对文献进行全面系统的综述,以评估特定干预措施对癌症诱发恶病质的作用。

方法

我们进行了一项系统综述,研究体育活动干预,特别是抗阻训练,对癌症诱发恶病质结局的疗效。我们在七个电子数据库(PubMed、Embase、EBSCO、SCOPUS、科学引文索引、PsychINFO、Cochrane)中检索截至2023年9月发表的文章,得到7项符合条件的研究。

结果

每项研究的样本量从20名到190名参与者不等。研究包括胰腺癌(n = 3)、头颈癌(n = 3)和胃肠道癌(n = 1)。平均年龄在51.90岁至67.1岁之间,女性占参与者的51%。大多数研究实施了抗阻训练干预(73%),持续时间从3个月到6个月不等。尽管结局模式显示出有希望的结果,但所有模型的效应量都很小且无统计学意义。

结论

尽管渐进性抗阻训练似乎是最有前景的对策,但改善癌症相关恶病质患者结局的运动干预科学仍在不断发展。作者鼓励开展高质量、充分有力的随机对照试验(RCT),以研究旨在减轻癌症诱发恶病质的体育锻炼干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/12421196/ee6c1448d3a3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/12421196/ee6c1448d3a3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/12421196/ee6c1448d3a3/gr1.jpg

相似文献

1
The role of resistance training in mitigating cancer-induced cachexia: A systematic review.抗阻训练在减轻癌症恶病质中的作用:一项系统综述。
Sports Med Health Sci. 2025 Jan 21;7(5):384-392. doi: 10.1016/j.smhs.2025.01.002. eCollection 2025 Sep.
2
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
3
Multimodal interventions for cachexia management.用于恶病质管理的多模式干预措施。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015749. doi: 10.1002/14651858.CD015749.pub2.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Exercise interventions on health-related quality of life for people with cancer during active treatment.积极治疗期间针对癌症患者健康相关生活质量的运动干预措施。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2.
6
Physical activity and exercise training in cystic fibrosis.囊性纤维化中的体力活动和运动训练。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD002768. doi: 10.1002/14651858.CD002768.pub5.
7
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
8
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
9
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
10
Exercise interventions for cerebral palsy.脑瘫的运动干预
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD011660. doi: 10.1002/14651858.CD011660.pub2.

本文引用的文献

1
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.癌症恶病质临床试验中的体重和组成终点:恶病质终点系列的系统评价 4。
J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):816-852. doi: 10.1002/jcsm.13478. Epub 2024 May 13.
2
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.癌症恶病质临床试验中的生活质量终点:恶病质终点系列的系统评价 3。
J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):794-815. doi: 10.1002/jcsm.13453. Epub 2024 Mar 29.
3
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
癌症恶病质临床试验中的食欲和饮食摄入终点:恶病质终点系列的系统评价 2。
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):513-535. doi: 10.1002/jcsm.13434. Epub 2024 Feb 11.
4
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.癌症恶病质临床试验中的身体功能终点:恶病质终点系列的系统综述 1。
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1932-1948. doi: 10.1002/jcsm.13321. Epub 2023 Sep 6.
5
Examining the Mechanisms behind Exercise's Multifaceted Impacts on Body Composition, Cognition, and the Gut Microbiome in Cancer Survivors: Exploring the Links to Oxidative Stress and Inflammation.探究运动对癌症幸存者身体成分、认知和肠道微生物群多方面影响背后的机制:探索与氧化应激和炎症的联系。
Antioxidants (Basel). 2023 Jul 14;12(7):1423. doi: 10.3390/antiox12071423.
6
PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.过表达 PGC-1α 不足以缓解雌雄小鼠的癌症恶病质。
Appl Physiol Nutr Metab. 2022 Sep 1;47(9):933-948. doi: 10.1139/apnm-2022-0086. Epub 2022 Jun 14.
7
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.癌症治疗期间的运动、饮食和体重管理:ASCO 指南。
J Clin Oncol. 2022 Aug 1;40(22):2491-2507. doi: 10.1200/JCO.22.00687. Epub 2022 May 16.
8
American Cancer Society nutrition and physical activity guideline for cancer survivors.美国癌症协会癌症幸存者营养与身体活动指南。
CA Cancer J Clin. 2022 May;72(3):230-262. doi: 10.3322/caac.21719. Epub 2022 Mar 16.
9
Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects.运动医学与癌症恶病质:靶向运动以对抗机制和治疗副作用。
J Cancer Res Clin Oncol. 2022 Jun;148(6):1389-1406. doi: 10.1007/s00432-022-03927-0. Epub 2022 Jan 27.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.